A reduction in pegfilgrastim doses among patients on myelosuppressive chemotherapy for breast cancer leads to a low incidence of neutropaenia-related events, including febrile and grade 3/4 neutropaenia, suggests a study.
People who eat yogurt appear to have a reduced risk of proximal colon cancer with a long latency period, a study has found. However, no significant benefit is seen for colorectal cancer (CRC) mortality.
Inflammatory biomarkers are linked to obesity, dyslipidaemia, and insulin resistance among adolescent and young adult survivors of childhood acute lymphoblastic leukaemia (cALL), a recent study has found.
For patients awaiting resection for urological malignancy, engaging in high-intensity interval training (HIIT) for 4 weeks yields improvements in cardiorespiratory fitness, cardiovascular health, and skeletal muscle, all of which represent a meaningful and achievable improvement in health status in the time available before surgery, according to a study.
Cancer survivors commonly fear the recurrence of their malignancy, which may be an important consideration in the supportive care needs of survivors, a new Hong Kong study has found. On the other hand, such fear does not seem to affect the use of psychosocial services.
Asian race appears to confer protection against the risk of prostate cancer, possibly due to biological, genetic, and/or lifestyle factors, according to data from the Reduction by Dutasteride of Cancer Events (REDUCE) study.
Combining the anti-PD-1 antibody sintilimab and a bevacizumab biosimilar significantly improves survival compared with the standard treatment of sorafenib in the first-line setting for patients with advanced, unresectable hepatocellular carcinoma (HCC), according to the ORIENT-32 study presented at ESMO Asia 2020.